These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 10713695)
1. Transforming growth factor alpha- and c-myc-induced mammary carcinogenesis in transgenic mice. Rose-Hellekant TA; Sandgren EP Oncogene; 2000 Feb; 19(8):1092-6. PubMed ID: 10713695 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice. Sandgren EP; Schroeder JA; Qui TH; Palmiter RD; Brinster RL; Lee DC Cancer Res; 1995 Sep; 55(17):3915-27. PubMed ID: 7641211 [TBL] [Abstract][Full Text] [Related]
3. Transgenic mice reveal roles for TGFalpha and EGF receptor in mammary gland development and neoplasia. Schroeder JA; Lee DC J Mammary Gland Biol Neoplasia; 1997 Apr; 2(2):119-29. PubMed ID: 10882298 [TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor alpha and mouse models of human breast cancer. Humphreys RC; Hennighausen L Oncogene; 2000 Feb; 19(8):1085-91. PubMed ID: 10713694 [TBL] [Abstract][Full Text] [Related]
5. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729 [TBL] [Abstract][Full Text] [Related]
6. TGFbeta1 and TGFalpha contrarily affect alveolar survival and tumorigenesis in mouse mammary epithelium. Booth BW; Jhappan C; Merlino G; Smith GH Int J Cancer; 2007 Feb; 120(3):493-9. PubMed ID: 17096338 [TBL] [Abstract][Full Text] [Related]
7. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis. Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672 [TBL] [Abstract][Full Text] [Related]
8. Development of hyperplasias, preneoplasias, and mammary tumors in MMTV-c-erbB-2 and MMTV-TGFalpha transgenic rats. Davies BR; Platt-Higgins AM; Schmidt G; Rudland PS Am J Pathol; 1999 Jul; 155(1):303-14. PubMed ID: 10393862 [TBL] [Abstract][Full Text] [Related]
9. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts. Schroeder JA; Troyer KL; Lee DC Oncogene; 2000 Jun; 19(28):3193-9. PubMed ID: 10918574 [TBL] [Abstract][Full Text] [Related]
10. Dual regulation of proliferation and apoptosis: c-myc in bitransgenic murine mammary tumor models. Jamerson MH; Johnson MD; Dickson RB Oncogene; 2000 Feb; 19(8):1065-71. PubMed ID: 10713691 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis. Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342 [TBL] [Abstract][Full Text] [Related]
12. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis. Amundadottir LT; Nass SJ; Berchem GJ; Johnson MD; Dickson RB Oncogene; 1996 Aug; 13(4):757-65. PubMed ID: 8761297 [TBL] [Abstract][Full Text] [Related]
13. Impairment of mammary lobular development induced by expression of TGFbeta1 under the control of WAP promoter does not suppress tumorigenesis in MMTV-infected transgenic mice. Buggiano V; Schere-Levy C; Abe K; Vanzulli S; Piazzon I; Smith GH; Kordon EC Int J Cancer; 2001 May; 92(4):568-76. PubMed ID: 11304693 [TBL] [Abstract][Full Text] [Related]